Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Chemotherapy Induced Nausea and Vomiting
and you are
between 6 and 12
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine the dosing strategy for adolescents aged 6 to 12 years.

Provided treatments

  • Drug: Sancuso
  • Drug: IV granisetron
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01596413. The sponsor of the trial is Kyowa Kirin Pharmaceutical Development Ltd and it is looking for 16 volunteers for the current phase.
Official trial title:
An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso® Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 6 to 12 Years)